Skin & hair

Who Should Read Your Moles — the PA or the Dermatologist

Save

For most routine mole checks, a supervised physician assistant and a dermatologist are looking for the same features and using the same escalation rules — the real question isn't which clinician's title is on the door, it's whether the practice has a clear, fast path from a PA's exam to a dermatologist's when something doesn't look right. Here is what a PA visit typically covers, what the shared ABCDE vocabulary can and can't tell you, and when to ask for the dermatologist by name.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Can a PA check a mole as well as a dermatologist?

For a routine full-body skin check or a mole that has looked stable for years, a physician assistant working under a dermatologist's supervision generally performs the same exam a dermatologist would: visual inspection, a dermatoscope for closer magnification, and measurement or photography of anything worth tracking. The gap between the two clinicians opens up not at the exam itself but at judgment calls on ambiguous findings, where years of specialty training and pattern recognition across thousands of pigmented lesions still separate a dermatologist from a PA who has typically trained for a shorter period specifically in dermatology.

That gap is exactly why the arrangement works: a PA handles volume, and a dermatologist's judgment is reserved for the findings that actually need it, rather than every mole on every patient getting the same specialist-level scrutiny regardless of risk.

Why dermatology practices use PAs for skin checks at all

Dermatologists are unevenly distributed across the country and concentrated in metropolitan areas, and that dermatology workforce shortage is a major reason practices lean on supervised PAs and nurse practitioners to keep up with demand for routine skin checks 1. Using a PA for a stable mole or an annual screening exam frees the dermatologist's own calendar for biopsies, procedures, and the more ambiguous cases that need a specialist's direct judgment, which is also why a PA visit is often available sooner than a dermatologist's own next opening.

In a rural county with one or no dermatologists within a reasonable drive, a supervised PA is often the only realistic way to get a skin check at all within a reasonable timeframe, which makes the supervision arrangement — not just the exam itself — the detail worth confirming before booking.

What a PA visit typically covers, and how escalation works

A well-run PA-led skin check follows the same structure as a dermatologist's: a systematic look at the whole body, not just the mole someone called about, since a second unnoticed lesion is a common finding. Practices that use PAs for this work generally build in a same-day or same-week escalation path — the PA flags anything atypical, and the supervising dermatologist reviews photos or sees the patient directly, often without a separate referral or a second appointment months out.

Asking directly, before booking, whether that escalation path exists and how fast it moves is a reasonable question, and a practice that can't answer it clearly is worth reconsidering for anything beyond a routine check.

The ABCDE vocabulary belongs to both clinicians

Asymmetry, border irregularity, color variation, diameter, and evolution over time are the ABCDE features clinicians use to describe a mole worth a closer look, and both a PA and a dermatologist are trained to apply the same framework 2. It functions as a shared vocabulary for what to point out and photograph, not a checklist that clears a mole once none of the letters seem to apply — a mole can fail every ABCDE feature and still turn out to be something serious, which is exactly why the framework is taught to describe risk rather than to rule it out.

What differs between clinicians is less the vocabulary and more the volume of comparison cases behind it: a dermatologist who has examined thousands of pigmented lesions over a career has a denser mental library to weigh a borderline finding against, which is part of why an ambiguous case is the kind of finding worth routing upward rather than settling from a single visit.

When it's worth insisting on the dermatologist specifically

Certain situations shift the calculus toward requesting the dermatologist directly rather than accepting whichever clinician has the next opening: multiple atypical-looking moles, a personal or family history of melanoma, a history of significant sun exposure or blistering sunburns, immunosuppression from a transplant or a medication, or a specific mole that has already been flagged as changing by a PA, a primary care clinician, or the patient. None of these situations mean the PA's exam was inadequate — they mean the stakes of a wrong call are high enough that specialist judgment is worth asking for by name.

What happens once something is found

Once a lesion looks concerning enough to sample, the biopsy technique itself matters: a narrow, full-thickness sample — an excisional or saucerization biopsy rather than a superficial shave or partial punch — is generally preferred for a mole where melanoma is a real possibility, because it preserves the tissue detail needed for accurate staging if the result comes back as cancer 3. Guideline-level care for a confirmed melanoma also specifies excision margins based on how deep the tumor has grown and, for certain patterns, a staged excision technique — decisions that sit squarely within a dermatologist's specialty training even when a PA performed the original exam 4.

This is the practical reason the PA-to-dermatologist handoff matters more than the initial exam itself: the sampling technique used at the very first cut can affect how confidently a pathologist can stage the result later, so getting the right clinician involved before the biopsy, not just after an abnormal result, is worth asking about directly.

What the screening evidence does and doesn't say

A widely cited finding is worth reading precisely rather than as a reason to skip an exam altogether: the current evidence is considered insufficient to weigh the benefits and harms of a routine visual whole-body skin exam used to screen asymptomatic adults and adolescents with nothing already concerning them 5. That recommendation addresses population-wide screening programs — it says nothing about who should examine a specific mole that has already caught someone's attention, and it does not distinguish between a PA and a dermatologist performing that exam. The research gap is about whether to screen everyone routinely, not about which clinician should look at a mole someone is already worried about.

Common questions

For a routine screening exam or a mole that has looked the same for years, a supervised PA generally performs the same structured exam a dermatologist would. The gap widens for ambiguous or atypical findings, where a dermatologist's depth of training in pattern recognition across many pigmented lesions still matters, which is why a good PA-led practice builds in a fast escalation path rather than relying on the PA's judgment alone.

Ask directly: whether the PA works under a specific supervising dermatologist, how quickly that dermatologist reviews an atypical finding, and whether escalation happens the same day or requires a separate appointment. A practice that can answer clearly is generally a safer bet for anything beyond a routine check.

It's reasonable to if you have multiple atypical moles, a personal or family history of melanoma, significant past sun exposure, or immunosuppression from a transplant or medication. For a first routine screening with none of those factors, a supervised PA visit is a reasonable and often faster starting point.

No — it's the same descriptive framework regardless of which clinician applies it, and it's meant to flag what's worth photographing and reporting, not to clear a mole when the features aren't present. A mole can fail every ABCDE criterion and still need a biopsy, which is why the rule works as a shared vocabulary rather than a verdict.

Often the dermatologist reviews photos or the PA's documentation first rather than repeating the entire exam, then examines the specific lesion directly before deciding on a biopsy. The workflow varies by practice, which is why asking about the escalation process in advance is useful.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a Mole Needs the Dermatologist, Not Just a Screening Check

  • a mole that has changed size, shape, or color over recent weeks to months
  • a mole with more than one color or a noticeably irregular border
  • a new mole appearing after age 40
  • a mole that bleeds, itches persistently, or won't heal

This article explains the general division of labor between a PA and a dermatologist for mole checks. It is not a diagnosis; only an in-person exam can determine what a specific mole is.

References

  1. 1.Feng H, Berk-Krauss J, Feng PW, Stein JA (2018). Comparison of Dermatologist Density Between Urban and Rural Counties in the United States. JAMA Dermatology. PMID 28296988Supports that dermatologists are concentrated in metropolitan areas, a major reason practices use supervised PAs to expand capacity for routine skin checks.
  2. 2.Tsao H, Olazagasti JM, Cordoro KM, et al. (2015). Early detection of melanoma: reviewing the ABCDEs. Journal of the American Academy of Dermatology. PMID 25698455Supports the ABCDE criteria as a shared descriptive framework for early melanoma detection, used by both PAs and dermatologists to flag findings for closer evaluation.
  3. 3.American Family Physician (2011). Shave and Punch Biopsy for Skin Lesions. American Family Physician. linkSupports that a narrow full-thickness biopsy technique is preferred over a superficial shave or partial punch when melanoma is suspected, to preserve staging accuracy.
  4. 4.Swetter SM, Tsao H, Bichakjian CK, et al. (2019). Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2018.08.055Supports AAD guideline-level detail on melanoma biopsy technique, excision margins by tumor thickness, and staged excision for certain patterns — specialist-level decisions once a lesion is confirmed.
  5. 5.US Preventive Services Task Force (2023). Skin Cancer: Screening. US Preventive Services Task Force. linkSupports that current evidence is insufficient to assess routine, population-wide visual skin-cancer screening in asymptomatic people — distinct from evaluating an already-flagged mole, and silent on which clinician type should perform an exam.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy